ISMPP Insider
  • In Practice
  • From ISMPP
  • Polls & Perspectives
  • Content Lab
  • Visit ISMPP.org
Select Page

Poll Results: Level of Detail for Efficacy and Safety Data in a Clinical Study Publication?

Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...

Unlocking Evidence Impact: Aligning IEGPs and Strategic Publications for Smarter Communication

Richard White, Chief Operating Officer, Oxford PharmaGenesis, UK; Suzann Schiller, VP, Medical Strategy & Communications, Lumanity, PA, USA; Eric Low, Ethical Medicines Group (EMIG) Steering Group, Eric Low Consulting, UK; Anne Clare Wadsworth, Co-Founder &...

Cutting the Clutter: ISMPP’s ORION Task Force Aims to Streamline RFIs

Steve Palmisano, The Lockwood Group; Kim Gertsen, Daiichi Sankyo; Robert Matheis, International Society for Medical Publication Professionals; Todd Parker, GSK1. Email your questions and comments on this article to TheMAP@ismpp.org. RFI/RFP Challenges Call for Process...

Publication Alert: Patients as Partners in Medical Publications: The ISMPP Journey of Engagement

ISMPP is proud to announce that an article on its journey of engagement with patients as partners in medical publications was published on September 9, 2025 in Current Medical Research and Opinion (CMRO). Access Patients as Partners in Medical Publications: The ISMPP...

The Dark Side of Publishing: Predatory Journals and Congresses Under Scrutiny

Michael Nissen, Independent Medical Publications Professional, USA; Stephanie Daniels, Independent Medical Publications Professional, UK; Johanna Todd, Taylor & Francis Group, UK; Jennifer Fetting, Citrus Health Group; Pravin Bolshete, Sqarona Medical...
« Older Entries
Next Entries »

Categories

  • Content Lab
  • From ISMPP
  • Hot Topics
  • In Practice
  • Messages
  • Polls & Perspectives

Recent Posts

  • Making Science More Accessible: Publishing Standalone Plain Language Summaries of Publications
  • When a Bespoke AI Tool Falls Short: What Would You Do?
  • Advancing Plain Language in Clinical Research Communications
  • Slowing Down to Speed Up: Rethinking Productivity, Trust, and AI in MedComms
  • Shining the Spotlight: The Dark Side of Publishing Gets Even Darker

Archives

ISMPP Insider is an informational and educational service intended for ISMPP members and the broader medical communications community. It is not meant as a basis for individual companies to make policy and/or procedural decisions, which should be made in consultation with the company’s Legal and/or Compliance representatives. The articles in ISMPP Insider do not necessarily represent the views of ISMPP.

All contents © 2026 International Society for Medical Publication Professionals, Inc. (ISMPP)

ISMPP will grant limited permission to use postings and articles in ISMPP Insider for personal and noncommercial use. Permission requests or questions should be directed to ISMPP (ismpp@ismpp.org).

©ISMPP Insider is published by the International Society for Medical Publication Professionals (ISMPP). www.ismpp.org